| Literature DB >> 25923543 |
Fang Lee Lim1, Zailina Hashim1, Leslie Thian Lung Than2, Salmiah Md Said3, Jamal Hisham Hashim4, Dan Norbäck5.
Abstract
A prevalence study was conducted among office workers in Malaysia (N= 695). The aim of this study was to examine associations between asthma, airway symptoms, rhinitis and house dust mites (HDM) and cat allergy and HDM levels in office dust. Medical data was collected by a questionnaire. Skin prick tests were performed for HDM allergens (Dermatophagoides pteronyssinus, Dermatophagoides farinae) and cat allergen Felis domesticus. Indoor temperature and relative air humidity (RH) were measured in the offices and vacuumed dust samples were analyzed for HDM allergens. The prevalence of D. pteronyssinus, D. farinae and cat allergy were 50.3%, 49.0% and 25.5% respectively. Totally 9.6% had doctor-diagnosed asthma, 15.5% had current wheeze and 53.0% had current rhinitis. The Der p 1 (from D. pteronyssinus) and Der f 1 (from D. farinae) allergens levels in dust were 556 ng/g and 658 ng/g respectively. Statistical analysis was conducted by multilevel logistic regression, adjusting for age, gender, current smoking, HDM or cat allergy, home dampness and recent indoor painting at home. Office workers with HDM allergy had more wheeze (p= 0.035), any airway symptoms (p= 0.032), doctor-diagnosed asthma (p= 0.005), current asthma (p= 0.007), current rhinitis (p= 0.021) and rhinoconjuctivitis (p< 0.001). Cat allergy was associated with wheeze (p= 0.021), wheeze when not having a cold (p= 0.033), any airway symptoms (p= 0.034), doctor-diagnosed asthma (p= 0.010), current asthma (p= 0.020) and nasal allergy medication (p= 0.042). Der f 1 level in dust was associated with daytime breathlessness (p= 0.033) especially among those with HDM allergy. Der f 1 levels were correlated with indoor temperature (p< 0.001) and inversely correlated with RH (p< 0.001). In conclusion, HDM and cat allergies were common and independently associated with asthma, airway symptoms and rhinitis. Der f 1 allergen can be a risk factor for daytime breathlessness.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25923543 PMCID: PMC4414577 DOI: 10.1371/journal.pone.0124905
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Asthma and respiratory symptoms among office workers, stratified for gender and smoking (n = 695).
| Respiratory symptoms | Male (n = 232), n (%) | Female (n = 463), n (%) | OR | 95% CI | p-value | Non-smoker (n = 619), n (%) | Smoker (n = 72), n (%) | OR | 95% CI | p-value | Total (n = 695), n (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| 29 (12.6) | 78 (17.0) | 1.42 | 0.90 – 2.25 | 0.148 | 97 (15.7) | 10 (13.9) | 0.87 | 0.43 – 1.75 | 0.863 | 107 (15.5) |
|
| 14 (6.1) | 56 (12.2) | 2.15 | 1.17–3.95 |
| 65 (10.5) | 5 (6.9) | 0.64 | 0.25 – 1.64 | 0.415 | 70 (10.1) | |
|
| 11 (4.8) | 34 (7.4) | 1.60 | 0.79 – 3.21 | 0.252 | 40 (6.5) | 5 (6.9) | 1.08 | 0.41 – 2.83 | 0.875 | 45 (6.5) | |
|
| 13 (5.7) | 58 (12.6) | 2.40 | 1.28 – 4.47 |
| 67 (10.8) | 4 (5.6) | 0.49 | 0.17 – 1.37 | 0.165 | 71 (10.3) | |
|
| 25 (10.8) | 79 (17.2) | 1.72 | 1.07 – 2.78 |
| 95 (15.3) | 9 (12.5) | 0.79 | 0.38 – 1.64 | 0.604 | 104 (15.1) | |
|
| 29 (12.5) | 99 (21.4) | 1.90 | 1.22 – 2.98 |
| 118 (18.9) | 10 (13.9) | 0.69 | 0.34 – 1.39 | 0.339 | 128 (18.4) | |
|
| 18 (7.8) | 56 (12.2) | 1.64 | 0.94 – 2.87 | 0.090 | 67 (10.8) | 7 (9.7) | 0.89 | 0.39 – 2.01 | 1.000 | 74 (10.7) | |
|
| 51 (22.0) | 133 (28.7) | 1.43 | 0.99 – 2.07 | 0.068 | 168 (27.0) | 16 (22.2) | 0.77 | 0.43 – 1.39 | 0.481 | 184 (26.5) | |
|
|
| 22 (9.5) | 63 (13.6) | 1.50 | 0.90–2.51 | 0.140 | 80 (12.8) | 5 (6.9) | 0.51 | 0.20 – 1.30 | 0.184 | 85 (12.2) |
|
| 13 (5.6) | 54 (11.7) | 2.22 | 1.19 – 4.17 |
| 64 (10.3) | 3 (4.2) | 0.38 | 0.12 – 1.24 | 0.136 | 67 (9.6) | |
|
| 11 (4.7) | 45 (9.7) | 2.16 | 1.10 – 4.27 |
| 53 (8.5) | 3 (4.2) | 0.47 | 0.14 – 1.54 | 0.256 | 56 (8.1) | |
|
| 8 (3.4) | 41 (8.9) | 2.72 | 1.25 – 5.90 |
| 46 (7.4) | 3 (4.2) | 0.55 | 0.17 – 1.80 | 0.464 | 49 (7.1) | |
|
| 12 (5.2) | 49 (10.6) | 2.17 | 1.13 – 4.17 |
| 58 (9.3) | 3 (4.2) | 0.42 | 0.13 – 1.39 | 0.187 | 61 (8.8) | |
|
|
| 56 (24.1) | 98 (21.2) | 0.84 | 0.58 – 1.23 | 0.384 | 137 (22.0) | 17 (23.6) | 1.10 | 0.62 – 1.95 | 0.765 | 154 (22.2) |
|
| 134 (57.8) | 234 (50.5) | 0.75 | 0.54 – 1.03 | 0.077 | 325 (52.2) | 43 (59.7) | 1.36 | 0.83 – 2.23 | 0.262 | 368 (53.0) | |
|
| 76 (32.8) | 162 (35.0) | 1.11 | 0.79 – 1.54 | 0.611 | 212 (34.1) | 26 (36.1) | 1.09 | 0.66 – 1.82 | 0.793 | 238 (34.3) | |
|
| 30 (12.9) | 55 (11.9) | 0.91 | 0.56 – 1.46 | 0.713 | 73 (11.7) | 12 (16.7) | 1.51 | 0.77 – 2.93 | 0.252 | 85 (12.2) | |
aWheeze or whistling in the chest, daytime attacks of breathless at rest or at exercise, or nocturnal attacks of breathlessness during the last 12 months.
bCurrent asthma medication or asthma attacks during the last 12 months.
*p<0.05
**p<0.01
Comparison of asthma, rhinitis and eczema among participants and non-participants.
| Respiratory symptoms | Questionnaire | Skin prick test | Environmental data | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Participants (n = 695), n (%) | Non-participants | p-value | Participants (n = 462), n (%) | Non-participants (n = 233), n (%) | p-value | Participants with env. data (n = 506), n (%) | Participants without env. data (n = 189), n (%) | p-value | |
|
| 67 (9.6) | 10 (16.7) | 0.12 | 44 (9.5) | 23 (9.9) | 0.89 | 43 (8.5) | 24 (12.7) | 0.11 |
|
| 154 (22.2) | 16 (26.7) | 0.42 | 44 (18.9) | 110 (23.8) | 0.15 | 119 (23.5) | 35 (18.5) | 0.18 |
|
| 368 (53.0) | 28 (46.7) | 0.35 | 256 (55.5) | 112 (48.1) | 0.07 | 269 (53.3) | 99 (52.4) | 0.87 |
|
| 219 (31.5) | 15 (25.0) | 0.38 | 149 (32.3) | 70 (30.0) | 0.60 | 166 (32.8) | 53 (28.0) | 0.24 |
a Non-participants (one to two per office) were interviewed for selective questions
b Comparison by using Chi-square test for four field contingency tables
Fig 1Venn diagram for the distribution of subjects with a positive skin prick test to D. pteronyssinus, D. farinae and Felis domesticus in the group with skin prick test (n = 463).
Asthma and respiratory symptoms among office workers with skin prick test (n = 463), stratified for house dust mite (HDM) and cat allergy.
| Respiratory symptoms | No HDM allergy (n = 220), n (%) | Any HDM allergy (n = 243),n (%) | OR | 95% CI | p-value | No cat allergy (n = 345), n (%) | Cat Allergy (n = 118), n (%) | OR | 95% CI | p-value | Total (n = 463), n (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| 24 (10.9) | 54 (22.6) | 2.38 | 1.42 – 4.01 |
| 46 (13.4) | 32 (27.8) | 2.50 | 1.50 – 4.17 |
| 78 (17.0) |
|
| 13 (5.9) | 38 (15.9) | 3.01 | 1.56 – 5.82 |
| 29 (8.4) | 22 (19.1) | 2.57 | 1.41–4.68 |
| 51 (11.1) | |
|
| 10 (4.5) | 24 (10.0) | 2.34 | 1.09 – 5.02 |
| 18 (5.2) | 16 (13.9) | 2.93 | 1.44 – 5.95 |
| 34 (7.4) | |
|
| 21 (9.5) | 33 (13.7) | 1.49 | 0.84 – 2.69 | 0.193 | 35 (10.2) | 19 (16.2) | 1.71 | 0.94 – 3.13 | 0.095 | 54 (11.7) | |
|
| 26 (11.8) | 47 (19.4) | 1.80 | 1.07 – 3.02 |
| 49 (14.2) | 24 (20.5) | 1.56 | 0.91 – 2.68 | 0.109 | 73 (15.8) | |
|
| 34 (15.5) | 56 (23.0) | 1.64 | 1.02 – 2.63 |
| 60 (17.4) | 30 (25.4) | 1.62 | 0.98 – 2.67 | 0.060 | 90 (19.4) | |
|
| 19 (8.7) | 33 (13.6) | 1.66 | 0.92 – 3.02 | 0.106 | 36 (10.5) | 16 (13.7) | 1.36 | 0.72 – 2.55 | 0.397 | 52 (11.3) | |
|
| 46 (20.9) | 84 (34.6) | 2.00 | 1.31 – 3.04 |
| 82 (23.8) | 48 (40.7) | 2.20 | 1.41 – 3.43 |
| 130 (28.1) | |
|
|
| 12 (5.5) | 45 (18.5) | 3.94 | 2.02– 7.67 |
| 28 (8.1) | 29 (24.6) | 3.69 | 2.09 – 6.52 |
| 57 (12.3) |
|
| 8 (3.6) | 37 (15.2) | 4.76 | 2.17–10.47 |
| 21 (6.1) | 24 (20.3) | 3.94 | 2.10 – 7.39 |
| 45 (9.7) | |
|
| 6 (2.7) | 24 (9.9) | 3.91 | 1.57–9.75 |
| 15 (4.3) | 19 (16.1) | 4.22 | 2.07 – 8.62 |
| 34 (7.3) | |
|
| 6 (2.7) | 24 (9.9) | 3.91 | 1.57–9.75 |
| 14 (4.1) | 16 (13.6) | 3.71 | 1.75 – 7.86 |
| 30 (6.5) | |
|
| 6 (2.7) | 31 (12.8) | 5.22 | 2.13–12.76 |
| 17 (4.9) | 20 (16.9) | 3.94 | 1.99 – 7.81 |
| 37 (8.0) | |
|
|
| 27 (12.3) | 84 (34.6) | 3.78 | 2.33 – 6.11 |
| 58 (16.8) | 53 (44.9) | 4.04 | 2.55–6.39 |
| 111 (24.0) |
|
| 102 (46.4) | 155 (63.8) | 2.04 | 1.40–2.96 |
| 176 (51.0) | 81 (68.6) | 2.09 | 1.34 – 3.25 |
| 257 (55.5) | |
|
| 51 (23.2) | 113 (46.5) | 2.88 | 1.93 – 4.31 |
| 107 (31.0) | 57 (48.7) | 2.11 | 1.38 – 3.24 |
| 164 (35.5) | |
|
| 18 (8.2) | 44 (18.1) | 2.48 | 1.39 – 4.44 |
| 35 (10.1) | 27 (22.9) | 2.63 | 1.51 – 4.57 |
| 62 (13.4) | |
aWheeze or whistling in the chest, daytime attacks of breathless at rest or at exercise, or nocturnal attacks of breathlessness during the last 12 months.
bCurrent asthma medication or asthma attacks during the last 12 month
*p<0.05;
**p<0.01;
***p<0.001
Office environment and HDM allergens in the dust samples of 35 office rooms.
| Environmental Parameters | Median | Interquartile range (25 percentile -75 percentile) | Minimum-maximum |
|---|---|---|---|
|
| 556.2 | 376.2 – 581.2 | 267.0 – 935.4 |
|
| 658.0 | 421.3 – 1135.8 | 174.0 – 14107.0 |
|
| 1.0 | 0.6 – 1.2 | 0.1 – 2.4 |
Associations between asthma, respiratory symptoms, personal factors and home environment factors among office workers (n = 461) [OR(95%CI)].
| Variables | Wheeze or whistling in the chest | Wheezing or whistling when did not have cold | Any daytime breathlessness | Nocturnal attacks of breathlessness | At least one airway symptoms | Doctor-diagnosed asthma | Current asthma | Rhinitis in the past 12 months | Rhino-conjuctivitis | Nasal allergies medication in the past 12 months |
|---|---|---|---|---|---|---|---|---|---|---|
|
| 1.07 | 0.94 | 0.81 | 0.79 | 0.88 | 0.95 | 1.06 |
|
| 0.92 |
| (0.81–1.40) | (0.62–1.41) | (0.61–1.07) | (0.56–1.12) | (0.69–1.11) | (0.66–1.37) | (0.73–1.55) |
|
| (0.67–1.27) | |
|
|
|
|
|
| 1.60 |
| 2.08 | 1.03 | 1.38 | 1.23 |
|
|
|
|
| (0.96–2.66) |
| (0.88–4.51) | (0.65–1.63) | (0.85–2.26) | (0.62–2.43) | |
|
| 1.25 | 2.30 | 1.27 | 2.19 | 1.08 | 0.88 | 1.00 | 1.27 | 1.28 | 1.55 |
| (0.49–3.50) | (0.57–9.23) | (0.50–3.24) | (0.69–6.94) | (0.50–2.35) | (0.22–3.49) | (0.25–4.03) | (0.63–2.53) | (0.63–2.61) | (0.60–3.97) | |
|
|
| 1.69 | 1.63 | 1.77 |
|
|
|
|
| 1.97 |
|
| (0.69–4.15) | (0.94–2.83) | (0.90–3.50) |
|
|
|
|
| (0.99–3.91) | |
|
|
|
| 1.36 | 1.08 |
|
|
| 1.52 | 1.25 |
|
|
|
| (0.76–2.43) | (0.53–2.21) |
|
|
| (0.92–2.53) | (0.76–2.06) |
|
*p-value<0.05
**p-value<0.01
***p-value<0.001
aWheeze or whistling in the chest, daytime attacks of breathless at rest or at exercise, or nocturnal attacks of breathlessness during the last 12 months.
bCurrent asthma medication or asthma attacks during the last 12 month
cOR calculated for 10 year increase in age
Each mutual adjustment model was analyzed by two-level logistic regression keeping age, gender, current smoking status, HDM allergy, cat allergy, any home dampness, indoor home painting in the last 12 months in the models.
Associations between asthma, respiratory symptoms, levels of Der p 1 and Der f 1in office dust samples and office floor carpeting among office workers (n = 371)[OR(95%CI)].
| Variables | Wheeze or whistling in the chest | Wheezing or whistling when did not have cold | Any daytime breathlessness | Nocturnal attacks of breathlessness | At least one airway symptoms | Doctor-diagnosed asthma | Current asthma | Rhinitis in the past 12 months | Rhino-conjuctivitis | Nasal allergies medication in the past 12 months |
|---|---|---|---|---|---|---|---|---|---|---|
|
|
| 0.84 | 0.81 | 0.85 |
| 0.89 | 0.70 | 0.97 | 0.90 | 1.11 |
|
| (0.53–1.34) | (0.61–1.08) | (0.60–1.21) |
| (0.59–1.33) | (0.45–1.10) | (0.76–1.24) | (0.71–1.15) | (0.75–1.65) | |
|
| 0.90 | 1.01 |
| 0.93 | 1.05 | 0.97 | 0.84 | 1.03 | 1.04 | 1.07 |
| (0.75–1.08) | (0.82–1.25) |
| (0.77–1.14) | (0.95–1.17) | (0.80–1.19) | (0.60–1.19) | (0.92–1.15) | (0.93–1.15) | (0.92–1.25) | |
|
| 0.96 | 0.55 | 0.60 | 1.03 | 0.98 | 1.00 | 0.91 | 1.07 | 0.85 | 0.81 |
| (0.51–1.82) | (0.19–1.605) | (0.32–1.12) | (0.48–2.18) | (0.58–1.66) | (0.42–2.37) | (0.35–2.35) | (0.63–1.81) | (0.50–1.46) | (0.34–1.93) |
*p-value<0.05
**p-value<0.01
aWheeze or whistling in the chest, daytime attacks of breathless at rest or at exercise, or nocturnal attacks of breathlessness during the last 12 months.
bCurrent asthma medication or asthma attacks during the last 12 month
cOR calculated for 100 ng/g increase in level of Der p 1 allergen
dOR calculated for 1000 ng/g increase in level of Derf 1 allergen
Each model was analyzed by two-level logistic regression and adjusting for age, gender, current smoking status, HDM allergy, cat allergy, any home dampness and indoor home painting in the last 12 monthsin the models.